Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Association of Nirmatrelvir Use With Severe COVID-19 Outcomes During the Omicron Predominance
- Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater
- Long-Term Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China
- Association of Vitamin D Supplementation With Risk of Incident Fractures in Middle-Aged and Older Adults
- Association of OSA With White Matter Integrity and Cognitive Performance in Middle to Late Adulthood
- Accuracy of Smartwatches for Detecting Atrial Fibrillation
- Role of a Single hs-cTnT Measurement in Excluding Acute Myocardial Injury and Infarction in the Emergency Department
- Oral Contraceptive Use, Hormone Replacement Therapy, and Stroke Risk
- Efficacy and Safety of Intramuscular Administration of Tixagevimab–Cilgavimab for Early Outpatient Treatment of COVID-19
- Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring